• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

426
71
48
47
24

COUNTRY

46
17
5
5
5

PRICE

292
545
1,153
1,438

PUBLISHED

70
113
512
1,438

PRODUCT TYPE

1,340
67
18
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Lamictal-Drug Insights,2014 Lamictal-Drug Insights,2014 - Product Thumbnail Image

Lamictal-Drug Insights,2014

“Lamictal XR - Drug Insights, 2014” provides Lamictal XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Trioptal-Drug Insights,2014 Trioptal-Drug Insights,2014 - Product Thumbnail Image

Trioptal-Drug Insights,2014

“Trioptal - Drug Insights, 2014” provides Trioptal marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Intuniv-Drug Insights,2014 Intuniv-Drug Insights,2014 - Product Thumbnail Image

Intuniv-Drug Insights,2014

“Intuniv XR - Drug Insights, 2014” provides Intuniv XR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Diprivan EML-Drug Insights,2014 Diprivan EML-Drug Insights,2014 - Product Thumbnail Image

Diprivan EML-Drug Insights,2014

“Diprivan EML - Drug Insights, 2014” provides Diprivan EML marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US,...

February 2015
FROM
Opana ER-Drug Insights,2014 Opana ER-Drug Insights,2014 - Product Thumbnail Image

Opana ER-Drug Insights,2014

“Opana ER - Drug Insights, 2014” provides Opana ER marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Imitrex-Drug Insights,2014 Imitrex-Drug Insights,2014 - Product Thumbnail Image

Imitrex-Drug Insights,2014

“Imitrex - Drug Insights, 2014” provides Imitrex marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Dysport-Drug Insights,2014 Dysport-Drug Insights,2014 - Product Thumbnail Image

Dysport-Drug Insights,2014

“Dysport - Drug Insights, 2014” provides Dysport marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM

Neurotech Business Report

Neurotech Business Report is the first publication targeting the business of neurotechnology, the application of engineering techniques to human neural and information processing systems Each monthly...

February 2015
Analysis of Marriott International Analysis of Marriott International - Product Thumbnail Image

Analysis of Marriott International

Analysis of Marriott International Inc. A complete and comprehensive analysis of Marriott International Inc, includes an overview of the industry the company operates in, a PEST Framework Analysis of...

February 2015
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

February 2015
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

February 2015
FROM

The Older Adult Psychotherapy Treatment Planner, with DSM-5 Updates, 2nd Edition.

This timesaving resource features: - Treatment plan components for 30 behaviorally based presenting problems - Over 1,000 prewritten treatment goals, objectives, and interventions—plus space...

January 2015

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015 Summary This, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015’, provides...

January 2015
FROM

Obsessive-Compulsive Disorder - Pipeline Review, H1 2015

Obsessive-Compulsive Disorder - Pipeline Review, H1 2015 Summary This, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2015’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic...

January 2015
FROM

Sedation - Pipeline Review, H1 2015

Sedation - Pipeline Review, H1 2015 Summary This, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

January 2015
FROM

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015 Summary This, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015’, provides an overview of the Post-Traumatic Stress...

January 2015
FROM

Fatigue - Pipeline Review, H1 2015

Fatigue - Pipeline Review, H1 2015 Summary This, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

Brain Injury - Pipeline Review, H1 2015

Brain Injury - Pipeline Review, H1 2015 Summary This, ‘Brain Injury - Pipeline Review, H1 2015’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015 Summary This, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015’, provides an overview of the Secondary...

January 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.